Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

(BRRGF)

2.5000
+0.1900
+(8.23%)
At close: April 4 at 4:00:00 PM EDT
Currency in NOK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
848
848
354
389
774
Operating Expense
152,081
152,081
192,173
306,024
315,236
Operating Income
-151,233
-151,233
-191,819
-305,635
-314,462
Net Non Operating Interest Income Expense
11,953
11,953
1,418
3,513
5,100
Pretax Income
-139,282
-139,282
-190,401
-302,122
-309,364
Net Income Common Stockholders
-139,282
-139,282
-190,401
-302,122
-309,364
Diluted NI Available to Com Stockholders
-139,282
-139,282
-190,401
-302,122
-309,364
Basic EPS
-3.95
--
-13.30
-341.00
-303.91
Diluted EPS
-3.95
--
-13.30
-341.00
-303.91
Basic Average Shares
35,276.6350
--
14,313.0150
886.3640
1,018.7560
Diluted Average Shares
35,276.6350
--
14,313.0150
886.3640
1,018.7560
Total Operating Income as Reported
-151,234
-151,234
-191,819
-305,635
-314,464
Rent Expense Supplemental
994
994
3,727
3,331
2,447
Total Expenses
152,081
152,081
192,173
306,024
315,236
Net Income from Continuing & Discontinued Operation
-139,282
-139,282
-190,401
-302,122
-309,364
Normalized Income
-139,282
-139,282
-190,401
-302,122
-309,364
Interest Income
16,653
16,653
3,055
2,949
3,130
Interest Expense
4,700
4,700
578
321
53
Net Interest Income
11,953
11,953
1,418
3,513
5,100
EBIT
-134,582
-134,582
-189,823
-301,801
-309,311
EBITDA
-134,126
-134,126
-189,600
-300,918
-307,999
Reconciled Depreciation
456
456
223
883
1,312
Net Income from Continuing Operation Net Minority Interest
-139,282
-139,282
-190,401
-302,122
-309,364
Normalized EBITDA
-134,126
-134,126
-189,600
-300,918
-307,999
12/31/2021 - 7/23/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BZYR Burzynski Research Institute, Inc.
0.0450
0.00%
 
BLTE Belite Bio, Inc
58.80
+0.72%
 
CMMB Chemomab Therapeutics Ltd.
1.2000
+2.56%
 
BLPH
 
CGEN Compugen Ltd.
1.4400
-1.37%
 
BOLT Bolt Biotherapeutics, Inc.
0.3720
+3.05%
 
BCRX BioCryst Pharmaceuticals, Inc.
7.96
+1.79%
 
CRMD CorMedix Inc.
8.45
-0.59%
 
BCAB BioAtla, Inc.
0.3807
+10.03%
 
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%